Alydia Health raises $10m in Series B

Alydia Health, formerly known as InPress Technologies, said today it closed a $10 million Series B financing round to help support its technology platform designed to prevent maternal morbidity and mortality caused by postpartum hemorrhage. The round was led by the Global Health Investment Fund and joined by Astia Angles and other existing investors. As part of the round, Global Health Investment Fund managing partner Dr. Curt LaBelle will join the company’s board of directors. “Alydia Health’s solution for postpartum hemorrhage offers tremendous potential for mothers and families around the world, starting right here at home. At GHIF, we invest in therapies that improve and save lives around the world while generating attractive financial returns. Alydia’s promising clinical results thus far indicate strong potential to achieve on both of these measures. We look forward to the U.S. clinical evaluation and subsequent commercialization of this postpartum hemorrhage device,” Global Health Investment Fund managing partner Curt LaBelle said in prepared remarks. “We are thrilled to back this experienced, women-led executive team in tackling an important problem in women’s health. Our members saw significant potential for this investment based on the early results and the strong clinical partners involved in the Pearle study, which include pre-eminent U.S. centers and OB-GYN thought leaders. We are excited to work with the Alydia team to support the co...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Funding Roundup Women's Health alydiahealth Source Type: news